Felbamate.
Sofia
R D
RD
Preclinical and Clinical Research and Development, Wallace Laboratories, Cranbury, NJ.
Kramer
L
L
Perhach
J L
JL
Rosenberg
A
A
D000284:Administration, Oral; D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D015507:Drugs, Investigational / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004569:Electroencephalography / Q000187:drug effects; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D000078328:Felbamate; D006801:Humans; D048448:Phenylcarbamates; D011409:Propylene Glycols / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D051381:Rats
D000927:Anticonvulsants; D015507:Drugs, Investigational; D048448:Phenylcarbamates; D011409:Propylene Glycols; D000078328:Felbamate